News Blog

Expert advocates more clinical trials in Africa
The National Agency for Food and Drug Administration and Control says the World Health Organisation has added Paediatric Zinc Sulphate tablet by Swiss Pharma Nigeria Limited to its list of pre-qualified medicines.
Mammograms should start at 40 years, says US task force All women should get mammogram screening for breast cancer starting from age 40, rather than 50, an influential US health body announced Tuesday, a move…
Group links potbellies to increased risk of hypertension, diabetes An advocacy group, the National Action on Sugar Reduction, has cautioned Nigerians against the misconception that having potbellies is an indication of living a ‘good life’,…
Cancer-causing compounds found in everyday food —EU agency Cancer-causing chemical compounds called nitrosamines have been detected in a range of everyday foods and could pose a health risk to consumers.
Medium-risk adults don’t need extra COVID-19 vaccines, WHO says The World Health Organisation said on Tuesday it is no longer recommending additional COVID-19 vaccine booster doses for regular, medium-risk adults as the benefit was marginal.
Why some medications are harmful to elderly – Pharmacists Drug experts have called for caution in the prescription and administration of medications to the elderly, warning that some drugs can cause serious health problems for…
The World Health Organisation says although COVID-19 is disappearing from view, access to medicines that treat Non-Communicable Diseases remains out of reach for millions across the world.
A new United States Government study has discovered that a drug-resistant and potentially deadly fungus has been spreading rapidly through US healthcare facilities. The fungus, as reported by NBCNews, is a type of yeast called…
The Director of Intercountry Centre for Oral Health for Africa, Dr. Balarabe Sani, says Nigerians should learn preventive oral health practices. Sani said this on Monday in Jos at the World Oral Health day with…

Information

NIROPHARM is dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges. 

Some of the challenges that NIROPHRM is set  to tackle with all the resources it has at its disposal include: High cost of funds, Poor infrastructure, Poor IPR protection, Chaotic drug distribution, Lack of data for planning, High level of Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance particularly at the land borders